Share
USER HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.
Expanding the dimension of blood purification Working to save lives together.
Symposium Recording

ESICM Lives | The role of hemoadsorption in Intensive Care - Key learnings and best practice

Watch now
DIVI 2025

Dec 3-5, 2025 | Hamburg, Germany Save the date for our Campfire sessions focusing on direct dialogue and idea sharing (in German)

Program
Medizincontrolling Webinar-Reihe

26. November 2025 | Dokumentation in der Praxis: Fallstricke vermeiden

Programm und Anmeldung
CytoSorbents & Hemoadsorption

When it comes to critical health challenges, you can rely on us as your trusted partner.

We understand that healthcare professionals need to rely on advanced technologies designed to support high-quality patient care.

 

CytoSorbents’ adsorption technology is broadening the applications of blood purification, offering a mechanism to support physiological balance and assist in the management of harmful substances – complementary to conventional dialysis approaches.

Our Innovation

The Power of the Bead

Our solutions are based on proprietary, biocompatible, and highly porous polymer bead technology designed to adsorb selected substances from blood or plasma and to reduce elevated levels of certain potentially harmful compounds.

  • Our Solution

    CytoSorb 300

    Restore balance to support clinical management

    *Not available in the US
    Learn more about CytoSorb
  • Our Solution

    PuriFi

    Empowering independent hemoadsorption therapy

    *Not available in the US
    Learn more about PuriFi
  • Our Solution

    ECOS-300CY

    Supporting ex vivo organ perfusion through adsorptive removal of inflammatory mediators

    *Not available in the US
    Learn more about ECOS
  • Our Solution

    VetResQ

    CytoSorb technology designed for veterinary critical-care applications

    *Available only in the US
    Learn more about VetResQ
Our Team of Experts

Expertise you can count on the moment you need it.

Our Support

CytoSorbents in over 75 countries worldwide.

CytoSorbents

Voices around the world

world map
Critical Care
Dr. Voyka Gorjup
Ljubljana, Slovenia

The most prominent clinical effect is the lowering of vasopressors, hemodynamic stability, lowering of interleukins and in those patients who are on vvECMO…

Critical Care
Dr. Yatin Mehta
Gurgaon, India

CytoSorb is indicated for use in conditions where elevated levels of cytokine and/or bilirubin and/or myoglobin exist.

Critical Care
Dr. Tobias Hübner
Münsterlingen, Switzerland

The reason for us to use CytoSorb in the ICU was the lack of treatment options. We never had anything in sepsis, and CytoSorb® is the new star on the horizon.